4th Jun 2007 07:02
Advanced Medical Solutions Grp PLC04 June 2007 For Immediate Release 4 June 2007 Advanced Medical Solutions Group plc ("AMS" or "the Company") To exhibit at Growth Company Investor Show on 13 June 2007 Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalmedical technology company, today announces that it will be exhibiting at theforthcoming Growth Company Investor Show to be held at the Barbican ExhibitionHalls, London, on 13 June 2007. The Company will be represented by Don Evans, Chief Executive, and ChrisMeredith, Commercial Director, on Stand No. 68. This is an opportunity forinvestors to visit the stand and talk to the Company's senior management aboutrecent events, products, market strategies and growth plans for the future. Now in its third year, the Growth Company Investor Show brings together leadingsmall and mid-cap quoted companies giving existing and potential new investorsthe opportunity to meet and network with management teams and also to attend acomprehensive seminar programme. -ENDS- For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0)1606 545508 Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000 Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a UK based company developing and providingleading edge technology to the $15 billion global woundcare market. Founded in 1991 and quoted on AIM, the Company is focused on the design,development, manufacture and sale of advanced woundcare dressings and productsfor closing wounds and sealing tissue. AMS provides a full range of advanced woundcare products for sale in hospital,nursing home and community care markets. The main indications are for chronicwounds such as ulcers and pressure sores. These products pioneer the concept ofmoist wound healing to allow wounds to heal faster and with less pain andscarring if they remain moist. They protect the wound, deal with tissue fluidsand provide an optimal environment for healing to occur. AMS' resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove a product from design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products based uponcyanoacrylate adhesive technology which allow the closure of wounds followingtrauma or surgical incisions, or seal skin to protect against breakdown or woundinfection. These products address the emerging tissue adhesives and sealantssegment of the wound closure market. AMS' technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group